The KCNJ5 mutation carriers were younger (p < 0.001), had a shorter duration of hypertension (p = 0.018), higher DBP (p = 0.003), higher aldosterone level (p < 0.001), higher ARR (p = 0.003), and lower potassium level (p < 0.001) (Table 1). This evidence concerns the gene KCNJ5 and hypertensive disorder.